New York mesothelioma treatment and doctors are numerous throughout the state but especially in New York City. If you have received this challenging diagnosis and live in New York, you have excellent options for some of the best cancer care in the world.
New York Cancer Treatment Centers
Some of the best medical facilities in the world are in New York City. These include seven facilities designated as Comprehensive Cancer Centers by the National Cancer Institute. They received this designation for excellence in patient care as well as contributions to cancer research.
Any of these facilities can provide world-class treatment, and some even include mesothelioma specialists on staff:
- Montefiore Einstein Comprehensive Cancer Center. Located in the Bronx in New York City, this cancer center is primarily a research institution, which means it can provide mesothelioma patients with novel treatments in clinical trials. The facility can also treat patients through collaborations with other hospitals. This includes pleural mesothelioma patients who benefit from chemotherapy, surgery, radiation, and photodynamic therapy.[1]
- Memorial Sloan Kettering Cancer Center. Memorial Sloan Kettering is based in New York City but has locations in other parts of the state. Staff collaborates in multidisciplinary teams to treat both pleural and peritoneal mesothelioma. Patients benefit from world-class surgeons, chemotherapy, and advanced radiation therapies.[2]
- Cold Spring Harbor Laboratory. This is an NCI basic research facility that can provide patients with access to important clinical trials. The laboratory collaborates with hospitals in the area to get innovative treatments for patients who need them.[3]
- Herbert Irving Comprehensive Cancer Center. This cancer center at Columbia University in Manhattan conducts research and leads clinical trials while also treating patients. This is one of the few facilities in the country that provides cytoreductive surgery with HIPEC for peritoneal mesothelioma. Pleural mesothelioma patients benefit from the lung cancer team, which includes surgery, immunotherapy, chemotherapy, radiation therapy, and targeted therapies.[4]
- Roswell Park Comprehensive Cancer Center. Roswell’s collaborative teams provide mesothelioma patients with individualized, multidisciplinary treatment plans. These include surgery, chemotherapy, radiation, photodynamic therapy, immunotherapy, and personalized medicine. Peritoneal patients may receive HIPEC treatment.[5]
- The Tisch Cancer Institute. The Tisch Cancer Institute at Mount Sinai in New York City has world-renowned mesothelioma experts on staff. Patients benefit from experts and all types of medical professionals collaborating in their care. Clinical trials are also available to patients here.[6]
- Laura and Isaac Perlmutter Cancer Center. The Perlmutter Cancer Center is a part of NYU Langone Health. More than one mesothelioma specialist works here, which gives patients options. Medical teams use a multidisciplinary approach to provide patients with tailored treatments, including clinical trials.[7]
- Maimonides Medical Center. Maimonides is the first fully accredited cancer center in Brooklyn, New York. It is staffed by oncologists, radiation oncologists, surgeons, and other specialists who can treat lung cancer and pleural mesothelioma. Patients can also access clinical trials here.[8]
Mesothelioma Specialists in New York
New York residents with mesothelioma have many options when it comes to finding expert care and treatment.
Valerie W. Rusch, M.D.
A thoracic surgeon and Memorial Sloan Kettering, Dr. Rusch is a leading expert in treating pleural mesothelioma. She is the Vice-Chair of Clinical Research and Chair in Intrathoracic Cancers. Dr. Rusch treats patients using minimally invasive procedures whenever possible and video-assisted surgical systems. She also participates in clinical trials with mesothelioma patients.[9]
John A. Chabot, M.D.
Dr. Chabot is a surgeon at Columbia, specializing in treating gastrointestinal cancers like peritoneal mesothelioma. He contributes to research as well and helps bring clinical trials and novel treatments to patients.[10]
John M. Kane III, M.D.
Dr. Kane, at Roswell Park, is a surgical oncologist. One of his areas of specialty is cytoreductive surgery and HIPEC. HIPEC is one of the most effective treatments for peritoneal mesothelioma, but a procedure that is not available everywhere.[11]
Raja M. Flores, M.D.
Dr. Flores is a thoracic surgeon at Mount Sinai and one of the world’s leading specialists in pleural mesothelioma. He uses minimally invasive procedures and robotic or video-assisted surgeries to help treat his patients more effectively and with less recovery time. Dr. Flores is also dedicated to research to create better surgical procedures for mesothelioma patients that help them enjoy a greater quality of life, not just a longer life.[12]
Harvey I. Pass, M.D.
A thoracic surgeon at the Perlmutter Cancer Center, Dr. Pass is a leading expert in treating mesothelioma. In addition to surgical treatments, he has devoted his research to developing photodynamic therapy to treat mesothelioma patients. Dr. Pass has also worked on finding better methods for screening and detecting mesothelioma early.[13]
Daniel Sterman, M.D.
Dr. Sterman is a pulmonary and critical care specialist at Perlmutter. He directs the Multidisciplinary Pulmonary Oncology Program, which includes treatment for patients with pleural mesothelioma. Dr. Sterman leads clinical trials studying gene therapy and immunotherapy as mesothelioma treatments.[14]
Additional Mesothelioma Specialists in New York
- Sherif R.Z. Abdel-Misih, M.D., surgical oncologist, Renaissance School of Medicine at Stony Brook University, Stony Brook
- Prasad S. Adusumilli, M.D., thoracic surgeon, Memorial Sloan Kettering Cancer Center, New York City
- Igor Brichkov, M.D., thoracic surgeon and oncologist, Maimonides Medical Center, Brooklyn
- Kevin Becker, M.D., medical oncologist, Maimonides Medical Center, Brooklyn
- Zachary Brown, M.D., surgical oncologist, NYU Langone Health, New York City
- Robert J. Cerfolio, M.D., thoracic surgeon, NYU Langone Health, New York City
- Abraham Chachoua, M.D., medical oncologist, Perlmutter Cancer Center, New York City
- Todd L. Demmy, M.D., thoracic surgeon, Roswell Comprehensive Cancer Center, Buffalo
- Georgios V. Georgakis, M.D., surgical oncologist, Stony Brook Health, Stony Brook
- Giuseppe Giaccone, M.D., medical oncologist and hematologist, Weill Cornell Medicine, New York City
- Mark E. Ginsburg, M.D., thoracic surgeon, New York Presbyterian, New York City
- Balazs Halmos, M.D., thoracic oncologist, Montefiore Einstein Comprehensive Cancer Center, New York City
- Brian Henick, M.D., medical oncologist, Herbert Irving Comprehensive Cancer Center, New York City
- Steven D. Herman, M.D., thoracic surgeon, Maimonides Medical Center, Brooklyn
- Benjamin Herzberg, M.D., medical oncologist, Herbert Irving Comprehensive Cancer Center, New York City
- Michael David Kluger, M.D., general surgeon, Herbert Irving Comprehensive Cancer Center, New York City
- Michael Minarich, M.D., surgical oncologist, Vassar Brothers Hospital, Poughkeepsie
- Garrett M. Nash, M.D., surgical oncologist, Memorial Sloan Kettering Cancer Center, New York City
- Roman Perez-Soler, M.D., medical oncologist, Montefiore Einstein Comprehensive Cancer Center, New York City
- Charles A. Powell, M.D., pulmonologist and critical care physician, Icahn School of Medicine at Mount Sinai, New York City
- Andreas Rimner, M.D., radiation oncologist, Memorial Sloan Kettering Cancer Center, New York City
- Christian Rolfo, M.D., medical oncologist, Mount Sinai Health System, New York City
- Kenneth Rosenzweig, M.D., radiation oncologist, Icahn School of Medicine at Mount Sinai, New York City
- Jason Shaw, M.D., thoracic surgeon, Maimonides Medical Center, Brooklyn
- Charles B. Simone, M.D., radiation oncologist, Memorial Sloan Kettering Cancer Center, New York City
- Joseph Skitzki, M.D., surgical oncologist, Roswell Park Comprehensive Cancer Center, Buffalo
- Joshua R. Sonet, M.D., thoracic surgeon and oncologist, Herbert Irving Comprehensive Cancer Center, New York City
- Brendon M. Stiles, M.D., thoracic surgeon, Montefiore Einstein Comprehensive Cancer Center, New York City
- Tracey L. Weigel, M.D., thoracic surgeon, Westchester Medical Center, Valhalla
- Andrea Wolf, M.D., thoracic surgeon, Mount Sinai Health System, New York City
- Sai Yendamuri, M.D., thoracic surgeon, Roswell Park Comprehensive Cancer Center, Buffalo
- Marjorie G. Zauderer, M.D., medical oncologist, Memorial Sloan Kettering Cancer Center, New York City
Clinical Trials for Mesothelioma Patients in New York
With so many research institutes, New York always has many active clinical trials. Currently, there are 25 clinical trials recruiting mesothelioma patients. Participation in a trial presents a unique opportunity to benefit from advanced treatment unavailable elsewhere. These are just a few examples of trials in New York that mesothelioma patients may qualify to participate in:
- Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma. This unique study is investigating the use of a vaccine to stimulate the patient’s immune system to attack cancer cells.[15]
- Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma (MPM-PDT). This phase II trial is investigating the use of photodynamic therapy with or without surgery in patients with pleural mesothelioma.[16]
- A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma. In this study, researchers are testing the effectiveness and safety of treating pleural mesothelioma with immunotherapy drug Keytruda and the highest possible dose of intensity-modulated radiation therapy.[17]
- MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma (eVOLVE-Meso). This is a phase III study of a new medication used with standard chemotherapy. Patients with pleural mesothelioma and not candidates for surgery may qualify.[18]
If you have mesothelioma, you have a long, difficult road ahead of you. Having world-class cancer centers and mesothelioma specialists in your state will make the journey a little easier.
Mary Ellen Ellis
WriterMary Ellen Ellis has been the head writer for Mesothelioma.net since 2016. With hundreds of mesothelioma and asbestos articles to her credit, she is one of the most experienced writers on these topics. Her degrees and background in science and education help her explain complicated medical topics for a wider audience. Mary Ellen takes pride in providing her readers with the critical information they need following a diagnosis of an asbestos-related illness.
Dave Foster
Page EditorDave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.
References
- Montefiore. (n.d.). Lung Cancer and Chest Diseases.
Retrieved from: https://www.montefiore.org/lung-cancer-and-chest-diseases - Memorial Sloan Kettering Cancer Center. (n.d.). Mesothelioma.
Retrieved from: https://www.mskcc.org/cancer-care/types/mesothelioma - Cold Spring Harbor Laboratory. (n.d.). Cancer Center.
Retrieved from: https://www.cshl.edu/research/cancer/#clinical-collaborations - Columbia University. (n.d.). Herbert Irving Comprehensive Cancer Center.
Retrieved from: https://cancer.columbia.edu/ - Roswell Park Comprehensive Cancer Center. (n.d.). Mesothelioma.
Retrieved from: https://www.roswellpark.org/cancer/mesothelioma - Icahn School of Medicine at Mount Sinai. (n.d.). The Tisch Cancer Institute.
Retrieved from: https://icahn.mssm.edu/research/tisch - Perlmutter Cancer Center. (n.d.). Malignant Mesothelioma.
Retrieved from: https://nyulangone.org/conditions/malignant-mesothelioma - Maimonides Health. (n.d.). Cancer Center.
Retrieved from: https://maimo.org/treatments-care/cancer-center/ - Memorial Sloan Kettering Cancer Center. (n.d.). Valerie W. Rusch, MD, FACS.
Retrieved from: https://www.mskcc.org/cancer-care/doctors/valerie-rusch - Columbia University Herbert Irving Comprehensive Cancer Center. (n.d.). John A. Chabot, MD, FACS.
Retrieved from: https://cancer.columbia.edu/john-chabot-md-facs - Roswell Park Comprehensive Cancer Center. (n.d.). John M. Kane III, MD, FACS.
Retrieved from: https://physicianresources.roswellpark.org/participant/john-m-kane-iii-md-facs - Icahn School of Medicine at Mount Sinai. (n.d.). Raja M Flores, MD.
Retrieved from: https://icahn.mssm.edu/profiles/raja-m-flores - NYU Langone Health. (n.d.). Harvey I. Pass, MD.
Retrieved from: https://nyulangone.org/doctors/1104826460/harvey-i-pass - NYU Langone Health. (n.d.). Daniel H. Sterman, MD.
Retrieved from: https://nyulangone.org/doctors/1851325922/daniel-h-sterman - National Institutes of Health. (2023, June 2). Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma.
Retrieved from: https://clinicaltrials.gov/ct2/show/NCT04525859 - National Institutes of Health. (2023, September 1). Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma (MPM-PDT).
Retrieved from: https://clinicaltrials.gov/study/NCT02153229 - National Institutes of Health. (2024, June 4). A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma.
Retrieved from: https://clinicaltrials.gov/study/NCT04897022 - National Institutes of Health. (2024, May 23). MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma (eVOLVE-Meso).
Retrieved from: https://clinicaltrials.gov/study/NCT06097728